Abbildung 1: PASI-Verlauf während der fünfjährigen Anschlussstudie A2304E1 (mod. nach 2)
Novartis Cosentyx Abb 1
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.